Sterilization and Contraception Increase Lifespan Across Vertebrates
Nature, December 10, 2025
Executive Summary
This landmark comparative biology study demonstrates that permanent surgical sterilization and ongoing hormonal contraception increase life expectancy by 10-20% across vertebrate species, providing the first comprehensive evidence that reproductive processes fundamentally constrain adult survival independent of environment. Using data from 117 zoo-housed mammalian species and meta-analysis of 71 published studies across 22 vertebrate species, researchers found that inhibiting reproduction extends lifespan in both sexes, with males showing greater benefits from pre-pubertal castration and females protected primarily from infectious disease mortality. The findings reveal sex-specific mechanisms whereby male gonadal hormones during puberty create lasting organizational effects that reduce survival, while female reproduction imposes direct physiological costs that increase mortality risk, though ovariectomy improves lifespan at the expense of certain healthspan metrics.
Authors and Affiliations
Lead/Corresponding Author:
- Michael Garratt, PhD - Centre for Neuroendocrinology and Department of Anatomy, School of Biomedical Sciences, University of Otago, Dunedin, New Zealand
Senior Authors (contributed equally):
- Fernando Colchero, PhD - Department of Mathematics and Computer Science, University of Southern Denmark; Department of Primate Behavior and Evolution, Max Planck Institute for Evolutionary Anthropology, Leipzig, Germany
- Shinichi Nakagawa, PhD - Evolution and Ecology Research Centre, University of New South Wales, Sydney, Australia
Co-Authors (selected key contributors):
- Malgorzata Lagisz - University of New South Wales (meta-analysis)
- Johanna Staerk - Max Planck Institute/University of Southern Denmark (zoo data analysis)
- Christine Neyt - University of Otago (literature search)
- Michael B. Stout, José V.V. Isola - Oklahoma Medical Research Foundation (aging biology)
- Veronica B. Cowl, Susan L. Walker - EAZA Reproductive Management Group, Chester Zoo, UK
- Nannette Driver-Ruiz - Species360, Minneapolis (database access)
- Ashley D. Franklin, Monica M. McDonald, David M. Powell - AZA Reproductive Management Center, Saint Louis Zoo
- Jean-Michel Gaillard, Jean-François Lemaître - Université Lyon, France (evolutionary ecology)
- Dalia A. Conde - University of Southern Denmark (biodemography)
Institution Count: 13 institutions across 6 countries (New Zealand, Australia, Germany, Denmark, USA, UK, France)
Conflicts of Interest
Declared Conflicts: None
The authors explicitly state: "The authors declare no competing interests."
Funding Sources:
- Australian Research Council Discovery grants (DP210100812, DP230101248) - S.N. and M.L.
- Canada Research Excellence Chair Program (CERC-2022-00074) - S.N.
- National Institutes of Health grant P01-AG031719 - J.S.
- Species360 data access through Research Data Use Agreement 98486
Potential Undisclosed Interests:
- Several authors (V.B.C., N.D.-R., A.D.F., M.M.M., D.M.P., S.L.W.) work for zoo organizations that routinely perform contraception procedures examined in the study, though this represents domain expertise rather than financial conflict
- Access to Species360 proprietary database could be viewed as institutional partnership, though data access procedures are transparent
Data and Methodology
Study Design
Multi-pronged approach:
- Zoo database analysis: Species360 ZIMS (Zoological Information Management System) data from 117 mammalian species, 2005-2022
- Published literature meta-analysis: 71 studies across 22 vertebrate species (159 effect sizes)
- Healthspan meta-analysis: 47 rodent studies (194 effect sizes)
Primary Data Source - Zoo Animals
Sample:
- 117 species meeting criteria (≥30 individuals per sex/contraception type, ≥100 total)
- Species included primates, carnivores, artiodactyls, marsupials, rodents
- Males: 90 species with surgical sterilization, 7 with hormonal contraception
- Females: 48 species with hormonal contraception, 9 with surgical sterilization
Contraception Methods:
- Males: Primarily castration (gonadectomy); vasectomy in 2 species (lions, mandrills)
- Females: Hormonal contraceptives (progestin-based in primates, GnRH agonists in carnivores), surgical sterilization (mainly ovariohysterectomy)
Inclusion Criteria:
- Animals born/alive after January 1, 2005
- Survival assessed from age at sexual maturity onward
- Well-documented birth and death dates
- Contraception from Species360 database (surgical, hormonal, or immunological)
Analysis Method:
- Bayesian survival trajectory analysis (BaSTA package in R)
- Siler mortality model for age-specific survival
- Proportional hazards model to test contraception effects
- Competing risks analysis for cause of death (70 species subset with necropsy data)
Meta-Analysis - Published Literature
Search Strategy:
- Databases: Scopus, Web of Science, PubMed, BASE
- Time period: Studies published 1930-2021
- Systematic search with 93% sensitivity against benchmark papers
Inclusion Criteria:
- Original empirical data from vertebrates
- Permanent or long-lasting sterilization
- Survival assessed across sterilization period
- Wild-type species/strains (no genetic manipulation or disease models)
- Survival data reported by sex and treatment group
Species Coverage:
- 3 fish species (salmon, lamprey)
- 1 reptile species (lizard)
- 18 mammalian species including humans
- 159 effect sizes from 71 studies
Effect Size Calculation:
- Log response ratio (lnRR) comparing sterilized to control survival
- Variance calculated accounting for coefficient of variation
- Hierarchical meta-analysis controlling for phylogeny, study, and species effects
Healthspan Meta-Analysis
Focus: Long-term effects of gonadectomy on aging in rodents
Inclusion Criteria:
- Mice or rats only
- Gonadectomy ≥6 months before testing
- Sterilization before 12 months of age
- Testing at ≥12 months of age
- Healthspan metrics from established protocols (Richardson et al. 2016; Bellantuono et al. 2020)
Healthspan Categories Assessed:
- Cardiac function/pathology and size
- Cognition (maze tests, memory)
- Frailty and strength/balance
- Immune function
- Metabolism
- Muscle size
- Non-tumor pathology
- Sensory function
- Tumor incidence (mammary vs non-mammary)
- Voluntary activity
Sample: 194 effect sizes from 47 studies
Statistical Analysis
Zoo Data:
- Bayesian MCMC with Metropolis-Hastings algorithm
- 6 parallel chains, 60,000 iterations, 10,001 burn-in, thinning every 100
- Phylogenetic correlation matrix using Pagel's method
- Life expectancy calculated as remaining adult lifespan from sexual maturity
Meta-Analysis:
- Multilevel random-effects models (metafor package in R)
- Random effects: study ID, species ID, phylogeny
- Variance-covariance matrix for shared sampling errors
- I² statistics for heterogeneity assessment
- Publication bias testing via funnel plots and Egger regression
Moderator Analyses Tested:
- Sex (male vs female)
- Gonad removal (yes vs no in females)
- Study design (controlled vs uncontrolled)
- Environment (wild/semi-wild vs captive)
- Sham control (yes vs no)
- Age at sterilization (ordinal: birth, pre-puberty, puberty, adulthood)
Key Findings
Overall Lifespan Effects
Zoo Data (117 species):
- Overall increase: 10.19% (β = 0.097, 95% CI [0.005, 0.188])
- Males: 9.8% increase (β = 0.098, 95% CI [0.005, 0.191])
- Females: 9.3% increase (β = 0.093, 95% CI [-0.005, 0.190])
- No sex difference: Effect similar in both sexes (R² < 0.01%)
- Heterogeneity: High (total I² = 70.19%)
- Phylogeny explained 24.27%
- Residual variation 45.93%
Meta-Analysis (71 studies, 22 species):
- Overall increase: 17.70% (β = 0.164, 95% CI [0.079, 0.248])
- Publication bias-corrected: 10.10% (β = 0.096, 95% CI [0.014, 0.178])
- Very high heterogeneity: Total I² = 99.41%
- Species identity: 42.43%
- Study: 33.89%
- Phylogeny: 2.70%
- Residuals: 20.39%
Sex-Specific Patterns
Males:
- Castration consistently increases lifespan
- Vasectomy shows NO benefit (2 studies in mice/rats)
- Suggests testosterone/testicular hormones drive the effect
- Pre-pubertal castration more effective than post-pubertal
Females:
- Similar ~18% increase in both sexes (difference = 0.002, 95% CI [-0.065, 0.069])
- No difference by gonad removal status:
- Ovariectomy: Improves lifespan
- Hysterectomy/tubal ligation (ovaries intact): Also improves lifespan
- Difference estimate = 0.036, 95% CI [-0.071, 0.143], R² = 0.54%
- Exception - Human women:
- Surgical sterilization: Slight decrease (<1%, statistically significant)
- Likely reflects selection bias (healthier women less likely to need surgery)
Timing of Sterilization
Males - Strong Age Effect:
Zoo Data (46 species):
- Pre-pubertal surgery: ~14% increase
- Post-pubertal surgery: ~9% increase
- Difference: 6.5% greater benefit pre-puberty (β = 0.065, 95% CI [-0.069, 0.198])
- Stronger effect in non-primates: 8.4% difference (β = 0.084, 95% CI [0.001, 0.167])
- Primates show no timing difference: β = -0.047, 95% CI [-0.181, 0.087]
Meta-Analysis (79 effect sizes with age data):
- Ordinal relationship: Earlier castration → greater lifespan benefit
- Estimate = -0.124, 95% CI [-0.202, -0.046] per life stage category
- Interaction with sex: β = -0.168, 95% CI [-0.282, -0.055]
Females:
- Insufficient data across age groups
- No clear age-dependent pattern observed
Interpretation:
Gonadal hormones during puberty have organizational effects on male physiology that permanently reduce lifespan. These effects cannot be fully reversed by adult castration.
Cause of Death Analysis
70 species with necropsy data analyzed for cumulative incidence at 75% mortality
Females - Protected from:
- Infectious diseases: 13.4% reduction (β = -0.134, 95% CI [-0.217, -0.052])
- Consistent with pregnancy reducing immunity
- Non-infectious diseases: Significant reduction (confidence intervals exclude zero)
- Undetermined causes: Reduced cumulative incidence
Males - Protected from:
- Behavioral interactions: 12.8% reduction (β = -0.128, 95% CI [-0.207, -0.050])
- Includes trauma, accidents, aggression
- Linked to testosterone-mediated behavior changes
- Undetermined causes: Reduced cumulative incidence
Interpretation:
Each sex shows protection from specific mortality sources related to their reproductive biology, plus general mortality reduction.
Environmental Context
Wild/Semi-Wild vs Captive Environments:
- Greater benefit in wild: Difference = 12.2% (β = 0.122, 95% CI [0.006, 0.238], R² = 6.84%)
- Wild/semi-wild: Larger effect sizes
- Captive (lab, farm, zoo): Moderate effect sizes
Interpretation:
Prevention of reproduction and associated resource use provides greater survival advantage when resources are limited and competition is high.
Study Design Factors
Controlled vs Uncontrolled Studies:
- No significant difference (β = 0.081, 95% CI [-0.059, 0.221], R² = 4.12%)
- Controlled experiments tended toward larger effects but not statistically different
- Indicates effects are real, not artifacts of study design
Sham Controls:
- No effect of sham vs no sham (β = 0.063, 95% CI [-0.033, 0.159], R² = 1.94%)
- Surgery itself does not explain the survival benefit
Healthspan Effects in Rodents
47 studies, 194 effect sizes, gonadectomy before 12 months, tested after 12 months
Overall:
- Modest improvement: β = 0.109, 95% CI [0.010, 0.209]
- High heterogeneity: Total I² = 71.29%
- No publication bias detected (estimate = -0.252, 95% CI [-0.871, 0.366])
Males - Broad Healthspan Improvement:
- Overall: β = 0.133, 95% CI [-0.028, 0.294]
- Strong benefits in:
- Cognition (maze tests, memory)
- Strength/balance
- Non-tumor pathology (reduced fibrosis, degeneration)
- Reduced incidence of non-mammary tumors
- Improved across multiple health domains
Females - Mixed Effects:
- Overall: β = 0.100, 95% CI [-0.018, 0.218]
- Benefits:
- Major reduction in mammary tumors (large effect size)
- Reduced cardiac hypertrophy
- Fewer pituitary tumors
- Detriments:
- Worse cognition (learning, memory tests)
- Reduced voluntary activity
- Increased non-tumor pathology (e.g., fibrosis)
- Worse sensory function (cataracts)
Interpretation:
Males show lifespan extension WITH healthspan improvement. Females show lifespan extension DESPITE healthspan decline in several domains, likely reflecting loss of beneficial estrogen effects specific to ovariectomy. Authors hypothesize non-ovariectomy approaches (hysterectomy, tubal ligation) would avoid these negative healthspan effects while maintaining survival benefits.
Species-Level Patterns
Testes Mass Correlation (59 species):
- No relationship between relative testes mass and lifespan response
- Estimate = 0.0261, 95% CI [-0.0119, 0.0641]
- Interpretation: Sexual competition intensity doesn't predict castration benefit
Sex Difference in Lifespan:
- Castration does NOT preferentially benefit males in species with female-biased longevity
- No reduction in sex gap variance with male castration
- Interpretation: Castration benefits are independent of baseline sex differences
Taxonomic Breadth:
- Effects observed across mammalian orders
- Also in fish (including semelparous salmon/lamprey with large effects)
- Limited data in reptiles (1 species)
- NO data in birds (not included)
Human Studies:
- Castrated men: ~18% increase (overlaps with other species)
- Three historical populations included
- Similar magnitude to other mammals
- Women with surgical sterilization: <1% decrease (likely selection bias)
Strengths
1. Unprecedented Taxonomic Breadth
- First study to examine contraception effects across >100 mammalian species
- Includes species from diverse orders: primates, carnivores, ungulates, marsupials, rodents
- Zoo database provides standardized conditions across phylogenetically diverse taxa
- Demonstrates consistency of findings across vertebrate classes (fish, reptiles, mammals)
2. Rigorous Multi-Method Approach
- Three complementary datasets:
- Zoo animals (controlled environment, standardized care)
- Published literature (diverse environments and methods)
- Healthspan meta-analysis (mechanistic insights)
- Cross-validation of findings across independent data sources
- Convergent evidence strengthens causal inference
3. Sophisticated Statistical Methods
- Bayesian survival trajectory analysis accounts for censoring and uncertainty
- Phylogenetic correction prevents pseudo-replication from related species
- Multilevel meta-analysis appropriately models nested data structure
- Competing risks analysis for cause-specific mortality
- Publication bias assessment and correction
4. Large Sample Sizes and High Statistical Power
- Zoo data: Thousands of individuals per species
- Meta-analysis: 159 effect sizes from 71 studies
- Sufficient power to detect moderating effects
- Precision estimates provided for all effect sizes
5. Transparent Data and Methods
- All code publicly available (GitHub/Zenodo: 10.5281/zenodo.17333443)
- Detailed supplementary materials with species-specific survival curves
- Pre-registered protocol for healthspan meta-analysis (OSF)
- Clear inclusion/exclusion criteria
6. Mechanistic Insights
- Examined cause-specific mortality patterns
- Timing of sterilization analyses reveal developmental windows
- Healthspan data illuminate quality vs quantity of life trade-offs
- Sex-specific mechanisms identified
7. Control for Confounds
- Tested effect of study design quality (controlled vs uncontrolled)
- Assessed impact of sham procedures
- Environment as moderator examined
- Gonad removal vs retention compared
- Multiple sensitivity analyses conducted
8. Practical Relevance
- Informs zoo animal management decisions
- Provides evolutionary biology insights on reproduction-lifespan trade-offs
- Human health implications (menopause, hormone therapy)
- Conservation implications for wildlife contraception programs
9. Expert Collaboration
- Authors include world experts in:
- Survival analysis and biodemography (Colchero, Conde)
- Meta-analysis methodology (Nakagawa)
- Zoo animal management (AZA and EAZA reproductive specialists)
- Aging biology (Stout, Isola)
- Access to unique proprietary database (Species360)
10. Challenges Conventional Wisdom
- Demonstrates effects independent of environment (wild vs captive)
- Shows ovariectomy still beneficial despite estrogen loss
- Refutes idea that sexual selection intensity predicts castration benefits
- Pre-pubertal timing findings reveal organizational hormone effects
Weaknesses and Limitations
1. Zoo Data Lacks Individual-Level Contraception Details
- Critical limitation: Cannot distinguish specific contraception types within categories
- "Surgical" in males could be castration OR vasectomy (though authors use indirect evidence)
- "Hormonal" in females includes progestins, GnRH agonists, combinations (different mechanisms)
- Reliance on expert opinion and literature searches rather than verified individual records
- Impact: Reduces ability to identify optimal contraception methods
2. Observational Design in Zoo Study
- No randomization to contraception vs control groups
- Animals selected for contraception based on:
- Genetic diversity management
- Behavioral problems
- Health issues
- Surplus prevention
- Selection bias potential:
- Healthier animals may be selected for contraception (positive bias)
- Animals with health problems may be sterilized (negative bias)
- Behavioral problems may lead to sterilization (males with high testosterone?)
- Cannot definitively establish causation despite large effects
3. Limited Temporal Scope
- Zoo data only from 2005-2022 (17 years)
- Excludes historical data when different practices may have been used
- Concern: Husbandry improvements over time could confound results
- Cannot examine long-term evolutionary changes in zoo populations
4. Species360 Database Limitations
- Data quality depends on individual zoo record-keeping
- Not all deaths have cause determined (65% "undetermined" in necropsy data)
- Potential variation in diagnostic criteria across institutions
- Necropsy subset bias: Only 70 of 117 species with adequate cause of death data
- Proprietary database not fully publicly accessible (though data sharing allowed)
5. Healthspan Analysis Restricted to Rodents
- Only mice and rats examined for healthspan effects
- Generalizability uncertain to other taxa
- Cannot assess healthspan in zoo species or other mammals
- Missing data on healthspan for non-ovariectomy female sterilization methods
- Focus on ovariectomy may not reflect effects of hormonal contraception
6. Female Healthspan Trade-offs Under-explored
- Negative healthspan effects of ovariectomy clearly demonstrated
- But: No comparable healthspan data for hysterectomy or hormonal contraception
- Authors' hypothesis that non-ovariectomy methods avoid healthspan costs is untested
- Important for translating findings to human health recommendations
7. Publication Bias in Meta-Analysis
- Statistical evidence of small-study effects (studies with low n have larger effect sizes)
- Publication bias-corrected estimate (10%) notably lower than raw estimate (17.7%)
- Concern: True effects may be closer to conservative estimate
- Positive results more likely to be published
8. Heterogeneity Not Fully Explained
- Very high I² values (70-99%) indicate large unexplained variance
- Moderators tested explain only small proportions (R² often <10%)
- Unknown factors driving species-level variation in response
- Phylogeny, study design, environment explain some but not most heterogeneity
9. Limited Taxonomic Coverage in Meta-Analysis
- Only 22 species across all vertebrates
- No birds included
- Single reptile species
- Heavy bias toward laboratory rodents and domestic mammals
- Fish data only from semelparous species (may not represent typical fish)
10. Age at Sterilization Data Incomplete
- Only 79 of 159 meta-analysis effect sizes have clear age data
- Many studies pooled across age groups
- Female age effects not assessable due to insufficient data
- Limits understanding of developmental windows
11. Mechanism Remains Unclear
- Study demonstrates association, not mechanism
- Multiple possible pathways:
- Direct hormonal effects on aging
- Indirect effects via behavior
- Energy allocation shifts
- Metabolic changes
- Immune function changes
- Cannot distinguish among these mechanisms
- GH-IGF1 axis mentioned as potential mediator but not tested
12. Human Data Quality Concerns
- Historical castration studies subject to:
- Selection bias (who was castrated and why)
- Confounding by indication (health reasons for castration)
- Different medical care for castrated vs intact men
- Institutional vs community living conditions
- Women's surgical sterilization data:
- Confounded by indication for surgery
- Healthier women less likely to need sterilization
- Cannot separate sterilization effect from underlying health status
13. Cause of Death Categories Too Broad
- "Undetermined" represents 65% of deaths
- Broad categories (e.g., "non-infectious disease") mask specific pathologies
- Extended Data Fig. 1 shows heterogeneity within categories
- Limited ability to identify specific disease processes affected
14. Environmental Moderation Under-explored
- Wild vs captive shows difference but:
- Only 40 effect sizes from wild/semi-wild (small sample)
- Confounded with species (different species in different environments)
- "Wild" category includes very diverse conditions
- Cannot examine nutrition, social structure, predation separately
15. Sex Hormone Levels Not Measured
- Assume castration eliminates testosterone
- Assume hormonal contraception suppresses hormones
- No verification of hormone levels in zoo animals
- Individual variation in hormone response not captured
- GnRH agonists may have different effects than progestins (not distinguished)
16. Lifespan vs Healthspan Paradox Not Resolved
- Females show lifespan extension despite healthspan decline
- Unanswered questions:
- Is extended low-quality life desirable?
- What are welfare implications for zoo animals?
- How do mortality compression/expansion patterns change?
- Study focuses on lifespan, not disability-free lifespan
17. Regression to Mean Not Fully Addressed
- Extended Data Fig. 5 shows no reduction in sex gap variance
- But: Some correlation between baseline difference and effect size is expected statistically
- Methods to fully account for regression to mean could be stronger
18. Missing Moderators
- Diet quality not examined (likely important given environment effects)
- Social structure (group vs isolated housing)
- Reproductive history (number of prior offspring)
- Body mass/size effects (except testes mass)
- Captivity duration (zoo-born vs wild-caught)
19. Reporting Limitations
- Individual species survival curves only in supplements
- Many species-specific details not presented in main text
- Difficult to identify which specific species drive effects
- Family-level analyses mentioned but not shown in main figures
20. Statistical Power for Interactions
- Many moderator analyses show non-significant effects
- Unclear if truly no effect vs insufficient power
- Particularly for three-way interactions (sex × age × environment)
- Multiple comparisons not explicitly corrected (though Bayesian framework addresses this somewhat)
Clinical and Scientific Implications
Evolutionary Biology
- Strong support for reproduction-lifespan trade-offs at individual level
- Challenges previous null findings from correlational zoo studies (Ricklefs & Cadena 2007)
- Demonstrates trade-off persists independent of environment
- Sex differences in mechanisms but similar magnitude
- Supports disposable soma theory
Human Health Considerations
Women:
- Surgical menopause (ovariectomy) extends lifespan but may impair healthspan
- Suggests maintaining ovaries during hysterectomy may be preferable
- Caution: Study findings cannot directly inform individual medical decisions
- Natural menopause may offer evolutionary benefits (grandmother hypothesis supported)
Men:
- Historical castration data consistent with animal findings (~18% increase)
- Modern relevance limited (castration not medically indicated except for cancer)
- Testosterone replacement therapy implications uncertain
- May inform research on male aging and androgen effects
General:
- Reproductive hormones fundamentally influence aging
- Sex-specific mechanisms require sex-specific interventions
- Trade-offs between lifespan and healthspan must be considered
Zoo and Conservation Management
- Provides evidence base for contraception decisions
- Suggests contraception improves welfare via reduced mortality
- But: Female healthspan costs with ovariectomy should be considered
- Supports use of reversible contraception methods where possible
- Pre-pubertal male sterilization shows greater benefit (but welfare concerns)
Aging Research
- Identifies sex hormones as major longevity modifiers
- Suggests puberty as critical period for male lifespan determination
- GH-IGF1 axis as potential mediator warrants investigation
- Need for interventions that separate lifespan from healthspan effects
Methodological Advances
- Demonstrates value of zoo databases for comparative biology
- Shows Bayesian survival analysis applicable to large-scale databases
- Highlights importance of multi-method convergent evidence
- Model for future cross-species aging research
Bottom Line Assessment
This is a landmark comparative biology study that definitively demonstrates reproduction constrains adult survival across vertebrates, with important mechanistic insights into sex-specific aging processes. The extraordinary taxonomic breadth (117 mammalian species plus meta-analysis across 22 vertebrate species), convergent findings across independent datasets, and rigorous statistical methods provide compelling evidence for a fundamental life history trade-off.
The study's greatest strengths are its unprecedented scale, multi-method approach, and sophisticated handling of phylogenetic non-independence. The finding that effects persist across wild and captive environments, with controlled and uncontrolled studies showing similar results, strongly argues for causation despite the observational design of the zoo data.
The primary weaknesses center on inability to identify specific contraception mechanisms within categories, potential selection bias in zoo animals, and the troubling lifespan-healthspan dissociation in females. The healthspan findings are particularly important: while ovariectomy extends female rodent lifespan by ~18%, it impairs cognition, activity, and tissue health—suggesting the extra years may be of lower quality. This was not adequately explored for non-ovariectomy sterilization methods.
The human relevance is intriguing but limited. Historical castration data align with animal findings, but modern applicability is questionable. For women, the finding that ovariectomy improves lifespan while impairing healthspan provides mechanistic support for current clinical practice favoring ovarian conservation during hysterectomy—though the study cannot provide direct clinical guidance.
For evolutionary biology, this work provides the strongest evidence to date that reproduction-survival trade-offs operate at the individual level, not just across species. The sex-specific mechanisms—male effects mediated by pubertal hormone organization, female effects by ongoing reproductive costs—illuminate how natural selection shapes aging differently in males and females.
Scientific rigor is generally excellent, with transparent methods, public code/data sharing, and appropriate statistical modeling. The pre-registered healthspan analysis and systematic literature search enhance credibility. However, the high unexplained heterogeneity (I² 70-99%) indicates important moderators remain unidentified.
In the context of the AI-in-healthcare literature you typically review, this study is unusual—it's comparative biology rather than clinical science. But it demonstrates a methodological approach (large-scale database mining + systematic meta-analysis + mechanistic sub-studies) that could be applied to electronic health records to understand human aging, sex differences, and hormone effects.
Most important unanswered question: Can contraception methods that preserve gonadal hormone production (vasectomy in males, tubal ligation/hysterectomy without oophorectomy in females) provide the survival benefits WITHOUT the healthspan costs? The data suggest yes for survival, but healthspan was only assessed for gonadectomy.
This deserves publication in Nature. It fundamentally advances understanding of aging biology, provides actionable insights for zoo management, and opens new research directions in biogerontology.